The United States cosmetic industry operates under a powerful federal law that shapes how products are manufactured, labeled, marketed, and monitored. The Federal Food, Drug, and Cosmetic Act (FD&C Act) forms the foundation of cosmetic regulation in the United States and establishes the authority of the US FDA over cosmetic products.
Every cosmetic brand—whether domestic or international—must understand how the FD&C Act applies to their products. Compliance is no longer limited to basic labeling rules. With the introduction of the Modernization of Cosmetics Regulation Act (MoCRA), cosmetic oversight has expanded into mandatory registrations, product listings, safety substantiation, adverse event reporting, and enforceable good manufacturing practices.
XPRO America is a professional US FDA Consultancy that guides cosmetic companies through FD&C Act compliance and all related regulatory obligations.
Why the FD&C Act Matters for Cosmetic Companies
The FD&C Act gives the US FDA the legal power to regulate cosmetics to ensure products are not:
- Adulterated
- Misbranded
- Unsafe for consumer use
Unlike drugs, most cosmetics do not require premarket approval. However, this does not mean cosmetics are lightly regulated. Instead, responsibility is placed squarely on manufacturers and brand owners to ensure compliance before products reach the market.
Failure to comply with the FD&C Act can result in serious enforcement actions, including product recalls, import refusals, warning letters, and seizures.
How the FD&C Act Defines a Cosmetic
Under the FD&C Act, a cosmetic is any article intended to be applied to the human body for:
- Cleansing
- Beautifying
- Promoting attractiveness
- Altering appearance
Common examples include:
- Skin care products
- Hair care products
- Makeup
- Fragrances
- Nail products
- Personal hygiene items
If a product claims to treat or prevent disease or affect the structure or function of the body, it may fall under drug regulations rather than cosmetics. Proper classification is essential to avoid regulatory violations.
Expansion of FD&C Act Authority Through MoCRA
MoCRA amended the FD&C Act to modernize cosmetic regulation. This expansion strengthened US FDA authority and introduced mandatory compliance requirements for cosmetic companies.
Major additions include:
- Facility registration
- Cosmetic product listing
- Safety substantiation
- Adverse event reporting
- GMP expectations
- Mandatory recalls under certain conditions
These changes transformed cosmetic compliance from a voluntary system into a structured regulatory framework.
Facility Registration Under the FD&C Act
Cosmetic manufacturing and processing facilities must be registered with the US FDA.
This applies to:
- US-based facilities
- Foreign facilities exporting to the United States
Registrations must be:
- Submitted initially
- Renewed every two years
- Updated when changes occur
Foreign facilities must also appoint a US Agent.
XPRO America provides full facility registration and US Agent services.
Cosmetic Product Listing Obligations
Each cosmetic product marketed in the US must be listed with the US FDA.
A product listing includes:
- Product name
- Cosmetic category
- Ingredient list
- Associated facility registration
- Responsible person information
Product listings must be updated annually and when formulations change.
Product listing increases transparency and allows US FDA to monitor products in commerce.
Ingredient Regulation Under the FD&C Act
The FD&C Act prohibits or restricts certain ingredients in cosmetics. While most ingredients do not require pre-approval, companies must ensure their formulations are safe and legally permitted.
Key considerations include:
- Prohibited substances
- Restricted-use ingredients
- Color additive authorization
- Contaminant limits
If a cosmetic contains unsafe or prohibited ingredients, it is considered adulterated under the FD&C Act.
XPRO America conducts ingredient compliance reviews to identify risks early.
Safety Substantiation Requirements
Cosmetic companies must maintain adequate safety substantiation for every product.
Safety substantiation means having scientifically valid evidence demonstrating that the product is safe for its intended use.
Examples of safety evidence:
- Toxicological risk assessments
- Ingredient safety data
- Product testing
- Scientific literature reviews
US FDA may request these records during inspections.
XPRO America prepares organized safety substantiation dossiers.
Good Manufacturing Practices (GMP)
The FD&C Act requires cosmetics to be manufactured under sanitary and controlled conditions.
Core GMP principles include:
- Clean facilities
- Controlled production processes
- Equipment maintenance
- Raw material qualification
- Finished product testing
- Employee training
- Documented procedures
Non-compliance with GMP can render cosmetics adulterated.
XPRO America supports GMP implementation and audits.
Labeling Requirements Under the FD&C Act
Cosmetic labels must be truthful and not misleading.
Required label elements include:
- Product identity
- Net quantity of contents
- Ingredient declaration using INCI names
- Name and address of responsible company
- Warning statements when applicable
Claims must stay within cosmetic boundaries. Drug-type claims trigger additional regulatory requirements.
XPRO America reviews labels to ensure FD&C Act compliance.
Adverse Event Reporting
MoCRA requires serious adverse events associated with cosmetics to be reported to the US FDA within 15 business days.
Serious adverse events include:
- Hospitalization
- Life-threatening reactions
- Permanent impairment
- Birth defects
- Death
Records must be retained for six years.
XPRO America establishes reporting systems and documentation procedures.
Import Compliance Under the FD&C Act
Imported cosmetics must meet the same legal standards as US-manufactured products.
US FDA may refuse entry if products:
- Are misbranded
- Are adulterated
- Lack proper registration or listing
XPRO America assists foreign companies with import compliance.
Enforcement Authority Under the FD&C Act
The US FDA may take actions such as:
- Warning letters
- Mandatory recalls
- Product seizures
- Import alerts
- Injunctions
Strong compliance systems significantly reduce enforcement risk.
Business Benefits of FD&C Act Compliance
Companies that align with FD&C Act requirements gain:
- Faster market access
- Retailer confidence
- Consumer trust
- Reduced legal risk
- Strong brand reputation
Compliance supports long-term business growth.
How XPRO America Helps
XPRO America is a specialized US FDA Consultancy providing:
- Facility Registration
- Cosmetic Product Listing
- US Agent Services
- Ingredient Review
- Safety Substantiation
- GMP Consulting
- Labeling Review
- Adverse Event Reporting Systems
- Import Compliance Support
For professional regulatory assistance, contact support@xproamerica.com.
Final Insight
The Federal Food, Drug, and Cosmetic Act remains the cornerstone of cosmetic regulation in the United States. With MoCRA enhancements, compliance expectations are higher than ever.
Partnering with XPRO America allows cosmetic companies to meet FD&C Act obligations confidently while focusing on product innovation and market expansion.
Leave a Reply